Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000627:therapeutic use* / Q000633:toxicity; D001859:Bone Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use* / Q000633:toxicity; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy; D013311:Streptozocin / Q000627:therapeutic use* / Q000633:toxicity
D009607:Nitrosourea Compounds; D001761:Bleomycin; D013311:Streptozocin; D008130:Lomustine